SPX3,831.39+6.06 0.16%
DIA309.71-1.14 -0.37%
IXIC11,322.24+194.39 1.75%

BRIEF-Teva Says New Ajovy Injection Use In Patients With Migraine Presented At 2022 American Headache Society Annual Meeting

reuters.com · 06/09/2022 08:18
BRIEF-Teva Says New Ajovy Injection Use In Patients With Migraine Presented At 2022 American Headache Society Annual Meeting

- Teva Pharmaceutical Industries Ltd TEVA:

  • TEVA - NEW REAL-WORLD DATA EVALUATING AJOVY® (FREMANEZUMAB-VFRM) INJECTION USE IN PATIENTS WITH MIGRAINE PRESENTED AT 2022 AMERICAN HEADACHE SOCIETY ANNUAL MEETING

  • NEW REAL-WORLD DATA EVALUATING AJOVY® (FREMANEZUMAB-VFRM) INJECTION USE IN PATIENTS WITH MIGRAINE PRESENTED AT 2022 AMERICAN HEADACHE SOCIETY ANNUAL MEETING

Source text for Eikon: ID:nBw6mhmdza

Further company coverage: TEVA


((reuters.briefs@thomsonreuters.com;))